Why Did CG Oncology Plunge 10.78%? Insider Selling Sparks Concern

Generado por agente de IAAinvest Pre-Market Radar
martes, 22 de julio de 2025, 8:44 am ET1 min de lectura
CGON--

On July 22, 2025, CG Oncology's stock price dropped by 10.78% in pre-market trading, marking a significant decline for the company.

One of the key factors contributing to this decline is the recent insider selling activity. Director Leonard E. Post sold 2,000 shares of the company's stock on July 17, 2025. This transaction, along with the broader market sentiment, likely played a role in the stock's downward trajectory.

Additionally, the stock price forecast for CG OncologyCGON-- has been a topic of discussion among investors. The last trade made by Post Leonard E. on July 17, 2025, involved selling 2,000 shares, which could have influenced market perceptions and contributed to the stock's decline.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios